Trial Profile
Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 11 May 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 11 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Dec 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.